Biocon receives Health Canada approval for Bosaya and Vevzuo biosimilars to Prolia and Xgeva
Denosumab biosimilars approved in Canada to expand access for osteoporosis and cancer-related bone conditions
Denosumab biosimilars approved in Canada to expand access for osteoporosis and cancer-related bone conditions
The transition from an outsourced MRI model to an in-house facility marks more than an infrastructure upgrade
Deal includes 13 branded generic products across 55+ countries; acquisition expected to strengthen global anti-infective portfolio and expand regulated market presence
The collaboration will roll out an “agentic” AI platform across Merck’s research & development, manufacturing, commercial, and corporate operations
Growth was broad-based across segments
The ETHICON 4000 Stapler and ETHICON 3D Reloads are now approved for use in both open and laparoscopic surgeries across the European Union
C. P. Radhakrishnan urged graduates to uphold ethical standards and maintain a commitment to patient care
The move reinforces Croda’s push to fuel growth through high-impact innovation across its Consumer Care portfolio
Sanplatec is leading the industry in the field of containers and devices for cell culture and live transport
Approval for Albuterol Sulfate inhalation aerosol enables Cipla Limited to enter the $1.5 billion U.S. albuterol market
Subscribe To Our Newsletter & Stay Updated